Overview
Sorafenat 200 mg Tablets contain Sorafenib, a targeted cancer therapy used primarily to treat advanced kidney cancer (renal cell carcinoma), liver cancer (hepatocellular carcinoma), and thyroid cancer. As a kinase inhibitor, it works by blocking cancer cell growth and slowing the spread of tumors. Manufactured under stringent quality standards, Sorafenat is a generic alternative offering affordability without compromising efficacy.





